|
市場調査レポート
商品コード
1373848
避妊薬および避妊具の世界市場 (2023-2030年)：タイプ (経口避妊薬 (避妊ピル)・IUD) 別の規模・シェア・成長分析・予測Global Contraceptives Market Size, Share, Growth Analysis, By Type(oral contraceptives (birth control pills), intrauterine devices (IUDs)) - Industry Forecast 2023-2030 |
||||||
|
|||||||
| 避妊薬および避妊具の世界市場 (2023-2030年)：タイプ (経口避妊薬 (避妊ピル)・IUD) 別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月12日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の避妊薬および避妊具の市場規模は、2021年の232億米ドル、2022年の282億2,000万米ドルから、予測期間中は7.4%のCAGRで推移し、2030年には499億6,000万米ドルの規模に成長すると予測されています。
世界の避妊薬および避妊具の市場は大きな成長を遂げており、いくつかの要因によって牽引されています。家族計画に対する意識の高まり、性感染症 (STI) の有病率の上昇、効果的な避妊法に対する需要の高まりなどが、市場成長に寄与する主な要因です。さらに、長時間作用型可逆的避妊薬および避妊具 (LARC) の開発や幅広い避妊オプションのアベイラビリティなど、避妊技術の進歩も市場拡大に拍車をかけています。さらに、家族計画やリプロダクティブヘルスの促進を目的とした政府の取り組みやプログラムも、市場に有利な環境を生み出しています。
しかし一方で、社会的烙印、文化的障壁、特定地域における避妊具へのアクセスの制限といった課題が市場成長の抑制要因となっています。
当レポートでは、世界の避妊薬および避妊具の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の避妊薬および避妊具市場：タイプ別
- 市場概要
- 経口避妊薬 (避妊ピル)
- 子宮内避妊器具 (IUD)
- コンドーム
- 避妊パッチ
- 注射可能避妊薬
- もっと
- 世界の避妊薬および避妊具市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- Pfizer Inc.
- Bayer AG
- Merck & Co., Inc.
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Allergan plc
- Reckitt Benckiser Group plc
- Church & Dwight Co., Inc.
- Mankind Pharma Ltd.
- CooperSurgical, Inc.
- Medisafe Distribution Inc
- HLL Lifecare Limited
- Mayer Laboratories, Inc.
- Lupin Limited
- Okamoto Industries, Inc
- Actavis, Inc.
- Ansell Limited
- Cipla Limited
- anssen Pharmaceuticals, Inc.
Global Contraceptives Market size was valued at USD 23.20 billion in 2021 and is poised to grow from USD 28.22 billion in 2022 to USD 49.96 billion by 2030, growing at a CAGR of 7.4% in the forecast period (2023-2030).
The global contraceptives market is witnessing significant growth and is driven by several factors. Increasing awareness about family planning, rising prevalence of sexually transmitted infections (STIs), and the growing demand for effective contraceptive methods are key factors contributing to market growth. Additionally, advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs) and the availability of a wide range of contraceptive options, are further fueling market expansion. Moreover, government initiatives and programs aimed at promoting family planning and reproductive health are creating a favorable environment for the market. However, challenges such as social stigma, cultural barriers, and limited access to contraceptives in certain regions pose restraints to market growth. Nonetheless, the increasing emphasis on women's health and the rising acceptance of contraception as a means of empowerment are expected to drive the growth of the global contraceptives market in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Contraceptives Market Segmental Analysis
The global contraceptives market is segmented by type, application, and region. Based on type, the market can be segmented into oral contraceptives (birth control pills), intrauterine devices (IUDs), condoms, contraceptive patches, injectable contraceptives, and more. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Contraceptives Market Dynamics
Drivers of the Global Contraceptives Market
Increasing Awareness And Acceptance Of Family Planning And Reproductive Health
One key driver of the global contraceptives market is the increasing awareness and acceptance of family planning and reproductive health. As societies become more educated and aware about the importance of contraception in controlling population growth and promoting women's health, the demand for contraceptives has witnessed significant growth. Additionally, government initiatives and programs aimed at promoting family planning, along with the efforts of various organizations in spreading awareness about contraceptive methods, have also contributed to the market's growth.
Restraints in the Global Contraceptives Market
Cultural And Religious Barriers That Limit The Use And Acceptance Of Contraceptives
A major restraint in the global contraceptives market is the cultural and religious barriers that limit the use and acceptance of contraceptives in certain regions. In some societies, there are cultural or religious beliefs that discourage or restrict the use of contraceptives, leading to lower adoption rates. Moreover, inadequate access to contraceptives, particularly in rural and remote areas, can also act as a restraint. Limited availability, affordability, and lack of proper distribution channels can hinder the widespread use of contraceptives, especially in developing countries. Overcoming these cultural and logistical challenges is crucial for the market's further growth and ensuring universal access to effective contraception methods.
Market Trends of the Global Contraceptives Key
One key market trend in the global contraceptives market is the increasing demand for long-acting reversible contraceptives (LARCs). LARCs include methods such as intrauterine devices (IUDs) and contraceptive implants. These methods offer a high level of effectiveness and convenience, as they require less frequent administration compared to other contraceptive options. LARCs are preferred by women seeking reliable and hassle-free contraception, contributing to their growing popularity. Additionally, advancements in technology have led to the development of more innovative and user-friendly LARCs, further driving their adoption. The trend towards LARCs reflects a shift towards more effective and sustainable contraceptive methods in the global market.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Contraceptives Market by Type
- Market Overview
- oral contraceptives (birth control pills)
- intrauterine devices (IUDs)
- condoms
- contraceptive patches
- injectable contraceptives
- and more
- Global Contraceptives Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson Services, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Allergan plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Reckitt Benckiser Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Church & Dwight Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mankind Pharma Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CooperSurgical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medisafe Distribution Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HLL Lifecare Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mayer Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lupin Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Okamoto Industries, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Actavis, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ansell Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- anssen Pharmaceuticals, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
